| No. of Trial | = |
| Hypnotics | 6 | 3 | 3 | 0
| Antianxiety | 23 | 8 | 14 | 1
| Psychiatric | 24 | 7 | 15 | 2
| Antidepressive | 20 | 0 | 17 | 3
| Others(Nervus) | 7 | 4 | 3 | 0
| Cerbrovascular | 56 | 18 | 36 | 2
| Hypertension | 55 | 13 | 41 | 1
| Cardiac | 35 | 18 | 16 | 1
| Digestive tract | 35 | 20 | 15 | 0
| Respiratory | 30 | 8 | 22 | 0
| Hyperlipidemia | 11 | 7 | 3 | 1
| Diabetes | 7 | 2 | 5 | 0
| Hepatic Disease | 8 | 6 | 1 | 1
| Renal Disease | 14 | 9 | 5 | 0
| Osteoporosis | 10 | 5 | 5 | 0
| NSAID | 60 | 12 | 46 | 2
| Urogenital | 21 | 8 | 10 | 3
| Ophtalmology | 13 | 1 | 10 | 2
| Antibiotics | 35 | 7 | 26 | 2
| Neoplastic | 5 | 2 | 3 | 0
| others | 21 | 8 | 13 | 0
| Total | 496 | 166 | 309 | 21
| |
|---|
FFavor for New Drag FNot Significantly FFavor for Standard Drag